Betamethasone And Neomycine
| Product/Composition:- | Betamethasone And Neomycine |
|---|---|
| Strength:- | 0.1% + 0.5% |
| Form:- | Drops |
| Packaging:- | 5ml |
| Therapeutic use:- | Eye and Ear Drops |
| Package Insert/Leaflet:- | Available upon request |
Introduction
We are a WHO-GMP certified pharmaceutical exporter supplying Betamethasone and Neomycin Eye and Ear Drops finished dosage formulations to importers and distributors across Africa, Southeast Asia, and the Middle East & CIS.
This combination formulation of Betamethasone (a synthetic corticosteroid) with Neomycin (an aminoglycoside antibiotic)Â is manufactured as a sterile ophthalmic and otic drop, optimized for accurate dose delivery, ocular/aural tolerability, and patient compliance across topical anti-inflammatory and anti-infective therapy.
Every shipment is backed by a complete regulatory dossier, enabling fast-track market authorization and MOH registration in your country.
Product Overview Table
| Field | Details |
| Product Name | Betamethasone and Neomycin Eye and Ear Drops |
| INN / Generic Name | Betamethasone Sodium Phosphate + Neomycin Sulphate |
| Therapeutic Class | Corticosteroid + Aminoglycoside Antibiotic Combination (Ophthalmic/Otic) |
| Indications | Steroid-responsive inflammatory conditions of the eye and ear with associated or suspected bacterial infection (e.g. conjunctivitis, blepharitis, otitis externa) |
| API Quality | Manufactured using DMF-grade Betamethasone Sodium Phosphate and Neomycin Sulphate |
| Pharmacopoeial Standard | BP / USP / IP (confirm applicable standard per buyer requirement) |
| Available Strengths | Betamethasone 0.1% w/v + Neomycin 0.5% w/v |
| Dosage Form | Sterile Eye and Ear Drops (multi-dose dropper bottle) |
| Shelf Life | 24 – 36 Months (unopened); in-use period per label after first opening |
| Storage | Store below 25°C, protect from light; discard as per in-use shelf life after opening |
| Manufacturing Facility | WHO-GMP Certified Facility – dedicated sterile ophthalmic/otic manufacturing line |
| Dossier Available | Yes, CTD / ACTD / eCTD format |
| Regulatory Documents | CoA, CoPP, FSC, MOA, GMP Certificate, Stability Data |
| Markets Served | Africa, Southeast Asia, Latin America, Middle East & CIS |
Product Variant, Dosage Form & Strength
Betamethasone and Neomycin Eye and Ear Drops (0.1% + 0.5% w/v)
Sterile multi-dose eye and ear drop for combined anti-inflammatory and anti-infective topical therapy
Key markets: Africa, Middle East, CIS, and Southeast Asian retail pharmacy and hospital channels
Keyword target: Betamethasone Neomycin eye drops exporter, Betamethasone Neomycin ear drops supplier
Pharmacopoeial Compliance
BP (British Pharmacopoeia) – Commonwealth, African, Middle East markets
USP (United States Pharmacopeia) – LATAM and global reference
IP (Indian Pharmacopoeia) – available on request
Regulatory & Dossier Support
Dossier Availability
CTD (Common Technical Document) – ICH-aligned and most regulated markets
ACTD (ASEAN Common Technical Dossier) – Philippines, Vietnam, Myanmar, Indonesia, Cambodia
eCTD (Electronic CTD) – for markets requiring electronic submissions
Country-specific dossier customization available on request
Dossier includes: Quality Module (Module 3), Safety & Efficacy summaries as applicable.
Sterility & Preservative Efficacy
As a sterile topical ophthalmic/otic formulation, Betamethasone and Neomycin Eye and Ear Drops is manufactured and tested to sterility and preservative-efficacy specifications rather than oral bioequivalence.
Preservative efficacy and sterility test data available on request to support regulated-market dossier submissions
Drug Master File (DMF)
API Drug Master File (DMF) references available for both Betamethasone Sodium Phosphate and Neomycin Sulphate, for cross-referencing in the buyer’s regulatory dossier
Helps reduce registration timelines in the importing country
CDSCO / Indian DMF available – reference acceptable for many markets
Manufacturing Compliance
WHO-GMP certified manufacturing facility
Site Master File (SMF) available for regulatory submissions
Facility audit-ready; inspection reports available on NDA basis
Dedicated sterile ophthalmic/otic manufacturing suite with aseptic filling – ensures sterility and particulate-free drop formulation.
Compliant with: NAFDAC (Nigeria), PPB (Kenya), TFDA (Tanzania).
Complete Documentation Package (Per Shipment)
| Document | Purpose |
| Certificate of Analysis (CoA) | Confirms product quality against specifications |
| Certificate of Pharmaceutical Product (CoPP / CPP) | Required for MOH registration in most countries |
| Free Sale Certificate (FSC) | Confirms product is freely sold in country of manufacture |
| Method of Analysis (MOA) | Lab testing methodology — required for dossier |
| GMP Certificate | Confirms manufacturing facility compliance |
| Stability Data | Real-time and accelerated — ICH Zone IVb for tropical markets |
| Batch Manufacturing Records (BMR) | Available on request (NDA basis) |
| Excipient Declarations | For all inactive ingredients used |
Clinical Indications & Therapeutic Information
Betamethasone and Neomycin Eye and Ear Drops combines a corticosteroid with an aminoglycoside antibiotic for topical use in the eye and ear.
Key indications: steroid-responsive inflammatory conditions of the eye (e.g. allergic/inflammatory conjunctivitis, blepharitis) and ear (e.g. otitis externa) with associated or suspected bacterial infection
Dosage and duration vary based on the site and severity of the condition – prescriber-guided
Manufactured in a dedicated sterile ophthalmic/otic facility, ensuring a particulate-free, preservative-validated formulation – a critical safety point for regulated-market buyers
High market demand in regions with significant burden of ocular and otic infections, including Africa, the Middle East, and Southeast Asia, driving consistent retail and institutional procurement volumes
Target Export Markets
Africa
Nigeria, Kenya, Tanzania, Ghana, Uganda, Ethiopia, Zambia, Cameroon, Côte d’Ivoire.
Focus: FSC, NAFDAC registration support (Nigeria), PPB (Kenya), TFDA (Tanzania), PCPB (Ghana)
Language: English, French labeling available for Francophone Africa
Southeast Asia
Philippines, Vietnam, Myanmar, Cambodia, Indonesia, Bangladesh
Focus: ACTD dossier format mandatory for ASEAN market registrations
Stability: Tropical formulations (ICH Zone IVb) – critical for this climate region
Latin America (LATAM)
Colombia, Peru, Ecuador, Bolivia, Guatemala, Honduras
Focus: Spanish labeling, USP pharmacopoeial standard preferred
Dossier: CTD format with local regulatory adaptation support
Middle East & CIS
Iraq, Yemen, Uzbekistan, Kazakhstan, Kyrgyzstan
Focus: GMP Certificate and CoPP are primary registration requirements
Language: Arabic and Russian labeling available on request
Export Packaging & Supply Chain
Primary Packaging Options
| Dosage Form | Packaging Options |
| Eye and Ear Drops | 5 mL / 10 mL LDPE dropper bottle with tamper-evident cap, individually cartoned |
| Bulk / Institutional Supply | Bulk pack for hospital/institutional procurement available on request |
Labeling & Customization
Private label manufacturing available with custom brand name and artwork
Multi-lingual labeling: English, French, Spanish, Portuguese, Arabic, Russian
Country-specific labeling compliance: NAFDAC text, KEBS, local registration number fields
Logistics & Supply
Incoterms: FOB, CIF, CFR, EXW – as per buyer requirement
Shipment lead time: 45 to 60 Days from order confirmation
Experienced in shipping to Africa, CIS, LATAM, and Southeast Asia
Why Source Betamethasone and Neomycin Eye and Ear Drops From Us?
WHO-GMP Certified Manufacturing: All formulations are manufactured under WHO-GMP standards in a dedicated sterile ophthalmic/otic facility. Audit-ready; GMP certificates and SMF available on request.
Complete Dossier for 100+ Countries CTD, ACTD, and eCTD dossiers pre-prepared. Reduces your market authorization timeline. Country-specific customization on request.
Validated Sterility & Preservative Efficacy Full sterility assurance and preservative-efficacy data available to support your dossier submission.
Private Label & Custom Packaging MOQ-based private labeling with your brand name, artwork, multilingual labeling, and country-specific regulatory compliance.
Competitive Ex-Works Pricing Direct manufacturer pricing with no middlemen. Volume-based pricing tiers available for distributors and government tenders.
End-to-End Regulatory Support: From CoA to CoPP to FSC, all export documentation handled. Dedicated regulatory team for MOH registration guidance.
Frequently Asked Questions (FAQ)
Q1. Do you provide a dossier for Betamethasone and Neomycin Eye and Ear Drops?
Yes. We provide complete dossiers in CTD, ACTD, and eCTD formats for Betamethasone and Neomycin Eye and Ear Drops. The dossier includes Module 3 quality documentation, stability data (ICH Zone IVb for tropical climates), sterility and preservative-efficacy references, and full site information. Country-specific customization and regulatory guidance are available for your MOH submission.
Q2. Is your Betamethasone and Neomycin Eye and Ear Drops manufactured in a dedicated/controlled facility?
Yes. Our Betamethasone and Neomycin Eye and Ear Drops are manufactured in a dedicated sterile ophthalmic/otic manufacturing suite under aseptic filling conditions. This is fully documented in our Site Master File (SMF), available for regulatory submissions.
Q3. Which pharmacopoeial standard do your Betamethasone and Neomycin Eye and Ear Drops comply with: BP, USP, or IP?
Our Betamethasone and Neomycin Eye and Ear Drops are available compliant with BP / USP / IP. Please specify your market requirement at the time of inquiry, and we will confirm the applicable standard for your order.
Q4. Can you supply Betamethasone and Neomycin Eye and Ear Drops under our private label?
Yes, we offer private label manufacturing for Betamethasone and Neomycin Eye and Ear Drops. We handle packaging artwork, multilingual labeling (English, French, Spanish, Portuguese, Arabic), and country-specific regulatory label compliance.
Q5. What is the MOQ for Betamethasone and Neomycin Eye and Ear Drops export?
MOQ varies by pack size. Please contact our export team with your product specification, target market, and estimated volume requirement for a tailored quotation and lead time confirmation.
Q6. Which countries do you export Betamethasone and Neomycin Eye and Ear Drops to?
We currently export to 40+ countries across Africa, Southeast Asia, Latin America, and the Middle East & CIS. Our regulatory team provides country-specific registration support for each market.
Q7. What documents do you provide with each Betamethasone and Neomycin Eye and Ear Drops shipment?
Standard export documentation includes: Certificate of Analysis (CoA), Certificate of Pharmaceutical Product (CoPP), Free Sale Certificate (FSC), Method of Analysis (MOA), GMP Certificate, Packing List, Commercial Invoice, and Bill of Lading. Additional documents (BMR, Stability Reports) available on request.
Q8. What is the in-use shelf life of Betamethasone and Neomycin Eye and Ear Drops after opening the bottle?
As with most multi-dose sterile drop formulations, an in-use discard period applies after first opening to maintain sterility and preservative efficacy.

